[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK5884D0 - Antibiotisk virksom forbindelse, fremgangsmade til fremstilling deraf og praeparat indeholdende forbindelsen - Google Patents

Antibiotisk virksom forbindelse, fremgangsmade til fremstilling deraf og praeparat indeholdende forbindelsen

Info

Publication number
DK5884D0
DK5884D0 DK0058/84A DK5884A DK5884D0 DK 5884 D0 DK5884 D0 DK 5884D0 DK 0058/84 A DK0058/84 A DK 0058/84A DK 5884 A DK5884 A DK 5884A DK 5884 D0 DK5884 D0 DK 5884D0
Authority
DK
Denmark
Prior art keywords
preparing
procedure
compound
preparation containing
antibiotic effect
Prior art date
Application number
DK0058/84A
Other languages
English (en)
Other versions
DK5884A (da
DK149776C (da
DK149776B (da
Inventor
Martti Lauri Antero Marvola
Esko Veikko Marttila
Jaakko Antero Uotila
Aino Kyllikki Pippuri
Pekka Juhani Kairisalo
Erkki Juhani Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of DK5884D0 publication Critical patent/DK5884D0/da
Priority to DK5884A priority Critical patent/DK149776C/da
Priority to NZ210606A priority patent/NZ210606A/en
Priority to IL73885A priority patent/IL73885A/xx
Priority to GB08432368A priority patent/GB2152502B/en
Priority to AU37059/84A priority patent/AU565688B2/en
Priority to US06/686,753 priority patent/US4599326A/en
Priority to PT79777A priority patent/PT79777B/pt
Priority to BE0/214265A priority patent/BE901411A/fr
Priority to SE8406671A priority patent/SE461854B/sv
Priority to IS2968A priority patent/IS2968A7/is
Priority to ZA8410143A priority patent/ZA8410143B/xx
Priority to NL8403979A priority patent/NL8403979A/nl
Priority to NO850007A priority patent/NO160263C/no
Priority to MA20540A priority patent/MA20316A1/fr
Priority to FR8500005A priority patent/FR2557878B1/fr
Priority to AT0000985A priority patent/AT386414B/de
Priority to FI850023A priority patent/FI77249C/fi
Priority to PL1985251457A priority patent/PL144349B1/pl
Priority to IE22/85A priority patent/IE57967B1/en
Priority to CA000471563A priority patent/CA1224461A/en
Priority to ES539349A priority patent/ES8605818A1/es
Priority to SU853836820A priority patent/SU1410866A3/ru
Priority to DE19853500179 priority patent/DE3500179A1/de
Priority to LU85721A priority patent/LU85721A1/fr
Priority to CS8596A priority patent/CS247191B2/cs
Priority to IT19012/85A priority patent/IT1184304B/it
Priority to YU20/85A priority patent/YU44485B/xx
Priority to HU8537A priority patent/HU196221B/hu
Priority to CH31/85A priority patent/CH666275A5/de
Priority to KR1019850000008A priority patent/KR900006237B1/ko
Priority to BG068285A priority patent/BG43189A3/xx
Priority to RO117230A priority patent/RO91262B/ro
Priority to JP60000744A priority patent/JPS60158197A/ja
Priority to PH31689A priority patent/PH22471A/en
Priority to MX203973A priority patent/MX156277A/es
Publication of DK5884A publication Critical patent/DK5884A/da
Publication of DK149776B publication Critical patent/DK149776B/da
Application granted granted Critical
Publication of DK149776C publication Critical patent/DK149776C/da
Priority to KE3841A priority patent/KE3841A/xx
Priority to CY1462A priority patent/CY1462A/xx
Priority to HK115/90A priority patent/HK11590A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
DK5884A 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen DK149776C (da)

Priority Applications (38)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
NZ210606A NZ210606A (en) 1984-01-06 1984-12-18 Acetyl erythromycin stearate, preparation and compositions
IL73885A IL73885A (en) 1984-01-06 1984-12-20 2'-o-acetyl erythromycin stearate,its preparation and antibiotic compositions containing it
GB08432368A GB2152502B (en) 1984-01-06 1984-12-21 An antibiotic compound a method for its preparation and compositions containing it
AU37059/84A AU565688B2 (en) 1984-01-06 1984-12-21 Acetyl erythromycin stearate
US06/686,753 US4599326A (en) 1984-01-06 1984-12-27 Acetyl erythromycin stearate, and compositions containing it
PT79777A PT79777B (en) 1984-01-06 1984-12-28 Process for preparing a novel antibiotic compound acetyl erythromycin stearate
BE0/214265A BE901411A (fr) 1984-01-06 1984-12-28 Compose antiobiotique, procede pour le preparer et compositions le contenant.
SE8406671A SE461854B (sv) 1984-01-06 1984-12-28 Acetylerytromycinstearat och terapeutisk komposition innehaallande det
IS2968A IS2968A7 (is) 1984-01-06 1984-12-28 Fúkkalyfjasamband, efnin sem það inniheldur og aðferðin til framleiðslu þess.
ZA8410143A ZA8410143B (en) 1984-01-06 1984-12-28 An antibiotic compound,a method for its preparation and compositions containing it
NL8403979A NL8403979A (nl) 1984-01-06 1984-12-31 Antibiotische verbinding, werkwijze voor de bereiding daarvan, alsmede preparaten die deze bevatten.
NO850007A NO160263C (no) 1984-01-06 1985-01-02 Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat.
MA20540A MA20316A1 (fr) 1984-01-06 1985-01-02 Compose antibiotique,procede pour le preparer et compositions les contenant
FR8500005A FR2557878B1 (fr) 1984-01-06 1985-01-02 Compose antibiotique, procede pour le preparer et compositions le contenant
AT0000985A AT386414B (de) 1984-01-06 1985-01-03 Verfahren zur herstellung des neuen 2'-acetylery- thromycinstearates
FI850023A FI77249C (fi) 1984-01-06 1985-01-03 Foerfarande foer framstaellning av en ny antibiotisk foerening.
ES539349A ES8605818A1 (es) 1984-01-06 1985-01-04 Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina
IE22/85A IE57967B1 (en) 1984-01-06 1985-01-04 An antibiotic compound,a method for its preparation and compositions containing it
CA000471563A CA1224461A (en) 1984-01-06 1985-01-04 Antibiotic compound, a method for its preparation and compositions containing it
PL1985251457A PL144349B1 (en) 1984-01-06 1985-01-04 Method of obtaining novel 2'-acetylerythromycin stearate
SU853836820A SU1410866A3 (ru) 1984-01-06 1985-01-04 Способ получени стеарата ацетилэритромицина
DE19853500179 DE3500179A1 (de) 1984-01-06 1985-01-04 Acetylerythromycinstearat, verfahren zu dessen herstellung und dieses enthaltende arzneimittel
LU85721A LU85721A1 (fr) 1984-01-06 1985-01-04 Compose antibiotique,procede pour le preparer et compositions le contenant
CS8596A CS247191B2 (en) 1984-01-06 1985-01-04 Method of acetylerythromycinstearate preparation
IT19012/85A IT1184304B (it) 1984-01-06 1985-01-04 Composto antibiotico,procedimento per la sua preparazione e composizioni che lo contengono
YU20/85A YU44485B (en) 1984-01-06 1985-01-04 Process for obtaining new antibiotic acetyl eritromycin stearate
HU8537A HU196221B (en) 1984-01-06 1985-01-04 Process for production of acetil-eritromicin-stearat and medical preparatives containing - as reagent - such compounds
CH31/85A CH666275A5 (de) 1984-01-06 1985-01-04 Acetylerythromycinstearat, verfahren zu dessen herstellung und dieses enthaltende arzneimittel.
KR1019850000008A KR900006237B1 (ko) 1984-01-06 1985-01-04 항생물질 화합물의 제조방법
BG068285A BG43189A3 (en) 1984-01-06 1985-01-05 Method for preparing of acetylic ester of erythromycine stearate
RO117230A RO91262B (ro) 1984-01-06 1985-01-07 Procedeu pentru prepararea stearatului de acetileritromicina
JP60000744A JPS60158197A (ja) 1984-01-06 1985-01-07 抗生物質およびその製法
PH31689A PH22471A (en) 1984-01-06 1985-01-07 Acetyl erythromycin stearate and compositions containing it
MX203973A MX156277A (es) 1984-01-06 1985-01-07 Procedimiento mejorado para preparar estearato de acetil eritromicina
KE3841A KE3841A (en) 1984-01-06 1988-10-28 An antibiotic compound,a method for its preparation,and compositions containing it
CY1462A CY1462A (en) 1984-01-06 1989-07-21 An antibiotic compound,a method for its preparation,and compositions containing it
HK115/90A HK11590A (en) 1984-01-06 1990-02-15 An antibiotic compound,a method for its preparation,and compositions containing it

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
DK5884 1984-01-06

Publications (4)

Publication Number Publication Date
DK5884D0 true DK5884D0 (da) 1984-01-06
DK5884A DK5884A (da) 1985-07-07
DK149776B DK149776B (da) 1986-09-29
DK149776C DK149776C (da) 1987-04-21

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Country Status (38)

Country Link
US (1) US4599326A (da)
JP (1) JPS60158197A (da)
KR (1) KR900006237B1 (da)
AT (1) AT386414B (da)
AU (1) AU565688B2 (da)
BE (1) BE901411A (da)
BG (1) BG43189A3 (da)
CA (1) CA1224461A (da)
CH (1) CH666275A5 (da)
CS (1) CS247191B2 (da)
CY (1) CY1462A (da)
DE (1) DE3500179A1 (da)
DK (1) DK149776C (da)
ES (1) ES8605818A1 (da)
FI (1) FI77249C (da)
FR (1) FR2557878B1 (da)
GB (1) GB2152502B (da)
HK (1) HK11590A (da)
HU (1) HU196221B (da)
IE (1) IE57967B1 (da)
IL (1) IL73885A (da)
IS (1) IS2968A7 (da)
IT (1) IT1184304B (da)
KE (1) KE3841A (da)
LU (1) LU85721A1 (da)
MA (1) MA20316A1 (da)
MX (1) MX156277A (da)
NL (1) NL8403979A (da)
NO (1) NO160263C (da)
NZ (1) NZ210606A (da)
PH (1) PH22471A (da)
PL (1) PL144349B1 (da)
PT (1) PT79777B (da)
RO (1) RO91262B (da)
SE (1) SE461854B (da)
SU (1) SU1410866A3 (da)
YU (1) YU44485B (da)
ZA (1) ZA8410143B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US7399488B2 (en) * 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2005041928A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for ehnanced absorption of iron
PT1765292T (pt) 2004-06-12 2017-12-29 Collegium Pharmaceutical Inc Formulações de fármacos dissuasoras de abuso
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
CA2714867A1 (en) 2006-06-23 2007-12-27 Candace B. Pert Non-aggregated pharmaceutically active peptide
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2836573C (en) 2011-05-18 2022-06-07 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
AU2013347975B2 (en) 2012-11-20 2018-07-26 Mederis Diabetes, Llc Improved peptide pharmaceuticals for insulin resistance
EP2922877B1 (en) 2012-11-20 2018-09-05 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
WO2015184177A1 (en) 2014-05-28 2015-12-03 Mederis Diabetes, Llc Improved peptide pharmaceuticals for insulin resistance
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
RU2019142102A (ru) * 2017-05-19 2021-06-21 Лунелла Байотек, Инк. Антимитосцины: направленные ингибиторы митохондриального биогенеза для эрадикации злокачественных стволовых клеток
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
KR102375232B1 (ko) 2018-02-06 2022-03-16 이지스 쎄라퓨틱스, 엘엘씨 비강내 에피네프린 제제 및 질환의 치료 방법
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
BR112021011963A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para alvejamento de mitocôndria e exterminação de células-tronco de câncer
AU2019402099A1 (en) * 2018-12-17 2021-07-08 Lunella Biotech, Inc. Triple combination therapies for anti-aging

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
HU196221B (en) 1988-10-28
SU1410866A3 (ru) 1988-07-15
FI77249B (fi) 1988-10-31
IE57967B1 (en) 1993-06-02
NO160263C (no) 1989-03-29
DK5884A (da) 1985-07-07
NZ210606A (en) 1987-08-31
GB8432368D0 (en) 1985-02-06
AU565688B2 (en) 1987-09-24
NL8403979A (nl) 1985-08-01
PT79777B (en) 1986-10-21
FI77249C (fi) 1989-02-10
PH22471A (en) 1988-09-12
IS2968A7 (is) 1985-04-03
PT79777A (en) 1985-01-01
GB2152502A (en) 1985-08-07
DK149776C (da) 1987-04-21
HUT37628A (en) 1986-01-23
YU2085A (en) 1987-12-31
ES539349A0 (es) 1986-04-01
MX156277A (es) 1988-08-04
YU44485B (en) 1990-08-31
IL73885A (en) 1988-10-31
DE3500179A1 (de) 1985-07-18
KR850005452A (ko) 1985-08-26
MA20316A1 (fr) 1985-10-01
FR2557878B1 (fr) 1988-01-15
AU3705984A (en) 1985-07-11
KR900006237B1 (ko) 1990-08-27
PL144349B1 (en) 1988-05-31
NO160263B (no) 1988-12-19
CA1224461A (en) 1987-07-21
DE3500179C2 (da) 1989-08-24
HK11590A (en) 1990-02-23
AT386414B (de) 1988-08-25
CY1462A (en) 1989-07-21
BG43189A3 (en) 1988-04-15
IE850022L (en) 1985-07-06
FI850023L (fi) 1985-07-07
DK149776B (da) 1986-09-29
RO91262B (ro) 1987-07-01
SE8406671D0 (sv) 1984-12-28
ZA8410143B (en) 1985-08-28
NO850007L (no) 1985-07-08
RO91262A (ro) 1987-06-30
KE3841A (en) 1989-04-07
SE461854B (sv) 1990-04-02
BE901411A (fr) 1985-04-16
LU85721A1 (fr) 1985-07-24
ES8605818A1 (es) 1986-04-01
IT8519012A0 (it) 1985-01-04
IT1184304B (it) 1987-10-28
GB2152502B (en) 1987-10-07
CH666275A5 (de) 1988-07-15
ATA985A (de) 1988-01-15
JPS60158197A (ja) 1985-08-19
FR2557878A1 (fr) 1985-07-12
SE8406671L (sv) 1985-07-07
FI850023A0 (fi) 1985-01-03
PL251457A1 (en) 1985-11-05
CS247191B2 (en) 1986-12-18
US4599326A (en) 1986-07-08
IL73885A0 (en) 1985-03-31
JPH029040B2 (da) 1990-02-28

Similar Documents

Publication Publication Date Title
DK5884A (da) Antibiotisk virksom forbindelse, fremgangsmaade til fremstilling deraf og praeparat indeholdende forbindelsen
DK163951C (da) Antibakterielt foderpraeparat og fremgangsmaade til fremstilling deraf
DK381485D0 (da) 1,2-benzisothiazol-3-yl-piperazinderivater og fremgangsmaade til fremstilling deraf
DK437286D0 (da) 2,5-diaryl-tetrahydrothiophenforbindelse og fremgangsmaade til fremstilling deraf
DK68285D0 (da) N-aryl-3-aryl-4,5-dihydro-1h-pyrazol-1-carboxamider, fremgangsmaade til fremstilling af forbindelserne, insekticider indeholdende forbindelserne og fremgangsmaade til bekaempelse af insekter
DK313086A (da) Phenoxyalkylisoxazol- eller -furanforbindelse og fremgangsmaade til fremstilling deraf
NO861114L (no) Fremgangsmaate for fremstilling av polyisocyanat-polyisocyanurater.
NO165143C (no) Fremgangsmaate til fremstilling av hydrokloridet av fenyl-1-dietylaminokarbonyl-1-aminometyl-2-cyklopropan (z).
DK239483D0 (da) Beta, gamma-dihydropolyprenylalkoholderivater og fremgangsmade til fremstilling heraf
NO853120L (no) Isfjell og fremgangsmaate for fremstilling av samme.
DK572183A (da) 7-carboxymethoxyphenylacetamido-3-cephemderivater, fremgangsmaade til fremstilling deraf og antibakterielle praeparater indeholdende forbindelserne
NO855026L (no) Aminoacyllabdaner og fremgangsmaate til fremstilling derav.
DK162221C (da) Cinnolinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende forbindelserne
DK315085D0 (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK165952C (da) 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf
DK52885D0 (da) 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf
DK418885D0 (da) 7-(pyridinyl)-1-alkyl-1,4-dihydro-4-oxo-3-quinolincarboxylsyre, fremgangsmaade til fremstilling deraf og antibakterielt praeparat indeholdende forbindelsen
NO164238C (no) Fremgangsmaate for fremstilling av pyridobenzodiazepinforbindelser.
DK575387D0 (da) Hydrofluorenderivater, fremgangsmaade til fremstilling deraf og praeparater indeholdende saadanne forbindelser
NO845134L (no) Dialkanoyloksybenzyliden-dialkanoat og fremgangsmaate til fremstilling derav.
NO875277L (no) Askorbat-2-polyfosfatforbindelser og fremgangsmaate til fremstilling derav.
DK486584A (da) R-z-4-amino-3-chlor-2-pentendisyre, fremgangsmaade til fremstilling deraf og antibakterielt praeparat indeholdende denne forbindelse
DK9384D0 (da) Dihydrodibenzotiepinderivat, farmaceutisk praeparat indeholdende derivatet og fremgangsmade til dets fremstilling
NO864258D0 (no) Skjema for patentprosedyrer og fremgangsmaate for fremstilling av dette.
DK375484A (da) 3-hydroxy-26,26,26,27,27,27-hexafluor-cholest-5-en-25-ol-forbindelserog fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
PUP Patent expired